GAS THERAPY SYSTEM FOR DELIVERY OF MEDICAMENT

    公开(公告)号:US20230133932A1

    公开(公告)日:2023-05-04

    申请号:US18061564

    申请日:2022-12-05

    Abstract: A gas therapy system (1) has a flow line (3, 2), a coupler (6) to a gas source, and an aerosol generator (4) for aerosol delivery, and a patient interface such as a nasal interface (2). A controller (10) is configured to modulate gas flow and aerosol delivery in real time. The controller changes gas flow rate and dynamically reduces aerosol delivery during upper gas flow rates such as 60 LPM, and activates aerosol delivery during lower gas flow rates of for example 10 LPM. The control may also include sensors to detect breathing, so that there is a bias towards increased aerosol delivery during inhalation in addition to during lower level gas flow.

    HIGH FLOW NASAL THERAPY SYSTEM
    2.
    发明申请
    HIGH FLOW NASAL THERAPY SYSTEM 审中-公开
    高流量NASAL治疗系统

    公开(公告)号:US20170021125A1

    公开(公告)日:2017-01-26

    申请号:US15301318

    申请日:2015-04-10

    Abstract: A high flow nasal therapy system (1) has a gas supply (2), a nebulizer (12), and a nasal interface (7). There are two branches (11, 10) and a valve (6) linked with the controller, the branches including a first branch (11) for delivery of aerosol and a second branch (10) for delivery of non-aerosolized gas. The controller controls delivery into the branches (11, 10), in which flow is unidirectional in the first and second branches, from the gas supply towards the nasal interface. The first branch (11) includes the nebulizer (12) and a line configured to store a bolus of aerosol during flow through the second branch (10). The valve (6) comprises a Y-junction between the gas inlet on one side and the branches on the other side.

    Abstract translation: 高流量鼻腔治疗系统(1)具有气体供应(2),雾化器(12)和鼻部接口(7)。 有两个分支(11,10)和与控制器连接的阀(6),分支包括用于输送气溶胶的第一分支(11)和用于输送非气雾化气体的第二分支(10)。 控制器控制从气体供应朝向鼻部界面的分支(11,10)中的输送,其中流动在第一和第二分支中是单向的。 第一分支(11)包括雾化器(12)和配置成在通过第二分支(10)的流动期间存储气溶胶团的管线。 阀(6)包括一侧的气体入口与另一侧的分支之间的Y形结。

    AEROSOL GENERATION
    4.
    发明申请

    公开(公告)号:US20210370336A1

    公开(公告)日:2021-12-02

    申请号:US17179950

    申请日:2021-02-19

    Abstract: A method for aerosolising a liquid comprises the steps of: providing an aperture plate having at least 100 outlet holes per mm2; delivering liquid to the aperture plate; and vibrating the aperture plate to produce an aerosol. The viscosity of the liquid is in the range of from 1 to15 cP and the surface tension of the liquid is in the range of from 72 to 0.5 mN/m. The output rate of the generated aerosol is greater than 0.01 mL/min.

    HIGH FLOW NASAL THERAPY SYSTEM
    5.
    发明申请

    公开(公告)号:US20200155788A1

    公开(公告)日:2020-05-21

    申请号:US16750507

    申请日:2020-01-23

    Abstract: A high flow nasal therapy system (1) has a gas supply (2), a nebulizer (12), and a nasal interface (7). There are two branches (11, 10) and a valve (6) linked with the controller, the branches including a first branch (11) for delivery of aerosol and a second branch (10) for delivery of non-aerosolized gas. The controller controls delivery into the branches (11, 10), in which flow is unidirectional in the first and second branches, from the gas supply towards the nasal interface. The first branch (11) includes the nebulizer (12) and a line configured to store a bolus of aerosol during flow through the second branch (10). The valve (6) comprises a Y-junction between the gas inlet on one side and the branches on the other side.

    AEROSOL GENERATION
    7.
    发明申请
    AEROSOL GENERATION 审中-公开

    公开(公告)号:US20180169691A1

    公开(公告)日:2018-06-21

    申请号:US15578923

    申请日:2016-06-10

    Abstract: A method for aerosolising a liquid comprises the steps of:—providing an aperture plate having at least 100 outlet holes per mm2; delivering liquid to the aperture plate; and vibrating the aperture plate to produce an aerosol. The viscosity of the liquid is in the range of from 1 to 15 cP and the surface tension of the liquid is in the range of from 72 to 0.5 mN/m. The output rate of the generated aerosol is greater than 0.01 mL/min.

Patent Agency Ranking